Enfermedades retinianas y nuevas terapias
Hospital Universitario Pío del Río Hortega
Valladolid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Pío del Río Hortega (6)
2022
-
Clinical Characterization of Inpatients with Acute Conjunctivitis: A Retrospective Analysis by Natural Language Processing and Machine Learning
Applied Sciences (Switzerland), Vol. 12, Núm. 23
2021
-
Recommendations for ophthalmologic practice during the easing of COVID-19 control measures
Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983
2019
-
Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN)
Progress in Retinal and Eye Research, Vol. 69, pp. 80-115
2018
-
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials
JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677
2015
-
Role of Systemic Anti-Tumor Necrosis Factor Alpha Treatment in the Reduction of Proliferative Vitreoretinopathy
Journal of Clinical & Experimental Ophthalmology, Vol. 06, Núm. 04
2006
-
Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization
Acta Ophthalmologica Scandinavica, Vol. 84, Núm. 6, pp. 743-748